SSRI Cost 2025–2026: Generic vs Brand Pricing for Common Antidepressants

Sertraline (Zoloft’s generic) costs about $10–$15 for a 30-day supply at most pharmacies. That’s a remarkable thing — one of the most effective treatments for depression and anxiety available costs less than a dinner out.

The brand-name version of that same drug runs $200–$300/month. That gap is the SSRI story in a nutshell.

What SSRIs Cost: Generic vs. Brand

Prices vary by pharmacy, dose, and whether you use GoodRx or a manufacturer coupon. The figures above are typical retail cash prices.

Why Generic SSRIs Are So Cheap

Most SSRIs lost patent protection years ago. Sertraline’s patent expired in 2006. Escitalopram (Lexapro) went generic in 2012. Once a drug goes off-patent, multiple manufacturers can produce it, driving prices down dramatically.

The FDA requires generic drugs to demonstrate bioequivalence — meaning they have the same active ingredient, dose, route of administration, and bioavailability as the brand. For SSRIs, the generic versions are clinically equivalent to the brands.

GoodRx and Discount Programs

Cash prices above reflect retail without any discounts. With GoodRx or similar programs, costs can drop further:

• Sertraline 100mg, 30 tablets: as low as $9 at some pharmacies with GoodRx
• Escitalopram 20mg, 30 tablets: often $8–$12 with discount cards
• Fluoxetine 40mg, 30 capsules: often $4–$10 with discount codes

Some pharmacies (Walmart, Costco, Sam’s Club) offer generic psychiatric medications on their $4/$10 generic lists — $4 for 30 days, $10 for 90 days.

Insurance Coverage for SSRIs

Most insurance plans cover at least one or two first-line generic SSRIs with a Tier 1 copay, often $5–$15/month. You’re almost certain to have at least sertraline or fluoxetine covered at low cost.

Brand-name SSRIs may require a step therapy requirement — your insurer may ask you to try the generic first. This is reasonable clinically and saves you money. Only if the generic fails (due to inactive ingredient sensitivity or documented clinical reason) will they cover the brand.

According to FDA data, approximately 90% of prescriptions dispensed in the U.S. are now generic. For antidepressants specifically, generic adoption is nearly universal.

Which SSRI Is Right for You?

That’s a clinical question, not a cost question — and your prescriber is the right person to answer it. That said, there are some cost-related nuances worth knowing:

• Sertraline and escitalopram are widely considered first-line for both depression and anxiety, and both are generic with low cost.
• Fluoxetine has the longest half-life of any SSRI, which can make discontinuation easier and is why it’s sometimes used to prevent SSRI discontinuation syndrome when stopping other SSRIs.
• Paroxetine has the most discontinuation issues of the SSRIs; it’s effective but harder to stop.
• Vilazodone (Viibryd) has no generic and costs $350–$450/month. Clinically, it’s not clearly superior to cheaper generics for most patients.

NIMH and APA Guidelines on SSRIs

The American Psychiatric Association’s Practice Guideline for MDD recommends SSRIs or SNRIs as first-line pharmacotherapy for moderate-to-severe depression. NIMH data shows that about 40–60% of patients with depression respond adequately to the first antidepressant tried, with response rates improving to 60–80% after trying a second agent if the first doesn’t work.

This means most patients will get adequate results from one of the cheap generic SSRIs — no need to start with an expensive brand.

Bottom Line

Generic SSRIs are one of the best bargains in medicine. For $10–$30/month — sometimes less with discount programs — you’re accessing medications with decades of safety data and strong efficacy for depression, anxiety, OCD, and PTSD. The brand versions at $200–$400/month offer no meaningful clinical advantage for the vast majority of patients. Start with a generic unless your prescriber has a specific reason not to.